More on RMTI
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Sales | 12.81M |
| Cost of Sales | 11.23M |
| Gross Profit | 1.58M |
| Selling, General and Administrative | 5.07M |
| Research and Product Development | 1.26M |
| Operating Income (Loss) | -4.75M |
| Interest and Dividend Income | 188.85K |
| Interest Expense | |
| Income (Loss) Before Income Taxes | -4.56M |
| Income Tax Expense | 0 |
| Net Income (Loss) | -4.56M |
| Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest | |
| Basic Earnings (Loss) per Share | -0.09 |
| Diluted Earnings (Loss) per Share | -0.09 |
Entities mentioned with RMTI
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
